PUBLISHER: DataM Intelligence | PRODUCT CODE: 1373373
PUBLISHER: DataM Intelligence | PRODUCT CODE: 1373373
A pen needle comprises a hollow needle fixed in a plastic hub and connects to the injection pen. Pen needles are available in different lengths and diameters. Health professionals also use these pen needles to inject different medications.
People with diabetes commonly use pen needles, as they require multiple insulin injections per day. Pen needles are intended to be used with a pen injector device for the subcutaneous injection of insulin. Insulin pen needles range from 4 millimeters to 12 mm in length, and 29 to 32 gauge in diameter.
Pen needles are frequently used by diabetics who frequently need many daily insulin injections. The increasing number of product launches for pen needles acts as a significant driver for market growth. Also, many significant companies play a major role in the advancements of the market by launching new treatment pen needles.
For instance, in May 2022, Roche Diabetes Care launched ACCU-FINE, a quality pen needle to make the process of insulin delivery smoother and virtually painless for people with diabetes. This needle features a unique tip cut to guarantee gentle insertion and a thin wall to promote quick insulin flow.
Also, in December 2021, Owen Mumford introduced the Unifine Ultra home-use pen needle. It is a one-of-a-kind home-use pen needle that is designed to offer a solution to help improve patient compliance and enhance the injection experience.
Furthermore, significant growth drivers such as the rising prevalence and incidence of diabetes, the geriatric population, and, the inclination toward minimally invasive procedures are expected to drive the market in the forecast period.
Pen needles are an easy, hassle-free mode of drug delivery but they are also associated with needlestick injuries and infections, hyperglycemia, and pain. Insulin pen therapy is seen to cause hyperglycemia in some patients, as the dose cannot be regulated. As a result, there has been a shift in diabetes treatment, from insulin pens to insulin pumps due to their ability to perform automated insulin suspension and decrease the risk of hypoglycemia.
The global pen needles market is segmented based on product type, length, application, distribution channel and region.
Pen needles generally do not require pinching of the skin for proper administration as happens in syringes. Standard pen needles are expected to hold the largest market share over the period forecast owing to increasing new standard pen needle launches and technical advancements.
For instance, in September 2022, Terumo Corporation introduced the FineGlide, a sterile pen needle for patients requiring regular insulin injections or other self-medication. This pen needle is designed as a 3-bevel super sharp needle with a high-grade silicone surface.
Additionally, in September 2020, HTL-STREFA introduced Droplet Micron which is a new and innovative pen needle that is a thinner and shorter pen needle and reduces the penetration force required for an injection.
The global pen needles market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa.
North America has maintained a significant market proportion due to factors such as the rising prevalence of diabetes, and healthcare expenditure in treating diabetes, this trend is anticipated to continue throughout the forecast period.
For instance, according to the Centers for Disease Control and Prevention 2022, an estimated 37.3 million people have diabetes in the U.S. and 28.7 million people including 28.5 million adults are diagnosed with diabetes. Hence, the demand for pen needles is increased for insulin drug delivery to diabetes patients.
Additionally, according to a Diabetes Canada report published in 2022, it states that there are 11.7 million Canadians living with diabetes or prediabetes. Also, the treatment of diabetes patients costs the healthcare system $30 billion annually. Therefore, due to the above factors, the usage of pen needles by diabetic patients for drug delivery increases which helps to boost the region's growth.
The COVID-19 pandemic has had a significant impact on the global pen needles market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular diagnoses, treatments, device launches, and consultations worldwide. With the outbreak of the pandemic, many pharmaceutical or medical device manufacturing units faced labor shortages and were unable to travel to work due to lockdown restrictions. Therefore, owing to the above factors, the pen needles market is expected to be moderately affected over the forecast period.
The major global players in the market include: Becton, Dickinson and Company, AdvaCare Pharma, Narang Medical Ltd., Nipro Corporation, Novo Nordisk A/S, B Braun SE, Allison Medical Inc., Terumo Corporation, Owen Mumford Trividia Health Inc. among others.
The global pen needles market report would provide approximately 69 tables, 70 figures, and 185 Pages.
LIST NOT EXHAUSTIVE